Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Malaria under arrest: New drug target prevents deadly transmission
Malaria under arrest: New drug target prevents deadly transmission
Australian researchers have found a new drug target for stopping the spread of malaria, after successfully blocking the world's deadliest malaria parasite—Plasmodium falciparum—from completing...
New animal model shows effective treatment for latent tuberculosis
New animal model shows effective treatment for latent tuberculosis
A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB.
Phase 1 clinical trials for psilocybin show no adverse effects
Phase 1 clinical trials for psilocybin show no adverse effects
A team of researchers from King's College London and mental healthcare company Compass Pathways has released the results of a Phase 1 clinical trial for the drug psilocybin.
Novartis drops asthma drug fevipiprant after trial failures
Novartis drops asthma drug fevipiprant after trial failures
ZURICH (Reuters) - Swiss drugmaker Novartis on Monday said it is jettisoning what it had hoped would be a billion-dollar-selling asthma drug, fevipiprant, from its development program after th...
Gilead's NASH combination treatment fails mid-stage study
Gilead's NASH combination treatment fails mid-stage study
(Reuters) - Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to dev...
Bayer asks U.S. appeals court to reverse $25 million Roundup verdict
Bayer asks U.S. appeals court to reverse $25 million Roundup verdict
(Reuters) - Bayer AG on Monday said it has asked a U.
U.S. government extends deadline to sign up for Obamacare insurance plans
U.S. government extends deadline to sign up for Obamacare insurance plans
(Reuters) - The U.
AZ, Daiichi’s targeted breast cancer therapy on target
AZ, Daiichi’s targeted breast cancer therapy on target
AstraZeneca and Daiichi Sankyo have presented new mid-stage data showing “clinically meaningful” responses in patients with advanced breast cancer taking trastuzumab deruxtecan.
The NHS robots performing major surgery
The NHS robots performing major surgery
2019 has seen a boom in the use of cutting edge robotic technology and there is more to come.
FDA changes course on Sarepta’s once-rejected muscular dystrophy drug
FDA changes course on Sarepta’s once-rejected muscular dystrophy drug
The Food and Drug Administration reversed its decision on a treatment for Duchenne muscular dystrophy from Sarepta Therapeutics (SRPT), approving a previously rejected drug without explaining ...
Senate confirms Stephen Hahn as new FDA chief
Senate confirms Stephen Hahn as new FDA chief
Dr.
FDA underscores that consumers should not use drugs, dietary supplements and devices recalled from Basic Reset and Biogenyx following consent decree for federal violations
FDA underscores that consumers should not use drugs, dietary supplements and devices recalled from Basic Reset and Biogenyx following consent decree for federal violations
The U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand